◦ Sinopharm
60,000 volunteers receive Chinese COVID-19 vaccines in phase-3 trials - China Nation News
Nation

60,000 volunteers receive Chinese COVID-19 vaccines in phase-3 trials

The two inactivated vaccines developed by China National Biotec Group CNBG which is affiliated to Sinopharm and the Wuhan Institute of Biological Products have started phase...
WeSure to offer better protection solutions - China Finance News
Finance

WeSure to offer better protection solutions

WeSure announces a strategic cooperation with Sinopharm Group and MedTree Health Technology as it aims to integrate private insurance and the health industry.
China coronavirus vaccine may be ready for public in November - China Nation News
Nation

China coronavirus vaccine may be ready for public in November

A unit of state pharmaceutical giant China National Pharmaceutical Group Sinopharm and US listed Sinovac Biotech are developing the three vaccines under the state s emergency use...
China approves emergency usage of COVID-19 vaccines - China Nation News
Nation

China approves emergency usage of COVID-19 vaccines

A potential coronavirus vaccine being developed by a unit of China National Pharmaceutical Group Sinopharm could cost no more than 1 000 yuan US 144 for two shots Sinopharm Chairman...
China Sinopharm's COVID-19 vaccine starts phase-3 clinical trials in Argentina - China Nation News
Nation

China Sinopharm's COVID-19 vaccine starts phase-3 clinical trials in Argentina

A Chinese inactivated COVID 19 vaccine has received approval for phase 3 clinical trials in Argentina on Friday according to the vaccine developer China National Biotec Group CNBG affiliated to Sinopharm.
China Sinopharm chief rules out high price for coronavirus vaccine - China Nation News
Nation

China Sinopharm chief rules out high price for coronavirus vaccine

Sinopharm has said its experimental vaccine could be ready by the end of this year.
Chinese COVID-19 vaccine shows promising trial results: research paper - China Nation News
Nation

Chinese COVID-19 vaccine shows promising trial results: research paper

The research paper provided an interim analysis of the phase 1 and phase 2 clinical trials of an inactivated COVID 19 vaccine developed by the Wuhan Institute of Biological Products under the China National Biotec Group CNBG affiliated to Sinopharm...
6 COVID-19 vaccine candidates, including 3 from China, now in phase-3 trials: WHO - World News
World

6 COVID-19 vaccine candidates, including 3 from China, now in phase-3 trials: WHO

The three Chinese candidates are from Sinovac Wuhan Institute of Biological Products Sinopharm and Beijing Institute of Biological Products Sinopharm said Michael Ryan executive...
Reality check of US unilateral demand for China to close Consulate-General in Houston - China Nation News
Nation

Reality check of US unilateral demand for China to close Consulate-General in Houston

The Beijing Institute of Biological Products under the China National Biotec Group a subsidiary of the China National Pharmaceutical Group Sinopharm has set up the world s largest...
China firm goes global with vaccine trial - Shanghai Metro News
Metro

China firm goes global with vaccine trial

Liu Jingzhen chairman of Sinopharm which the CNBG is affiliated to said the company will accelerate international cooperation in clinical trials and maintain close communication with...
Top